Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features

BACKGROUND AND PURPOSE: High-risk prostate cancer patients are frequently treated with external-beam radiotherapy (EBRT). Of all patients receiving EBRT, 15–35% will experience biochemical recurrence (BCR) within five years. Magnetic resonance imaging (MRI) is commonly acquired as part of the diagno...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Phys Imaging Radiat Oncol
Main Authors: Dinis Fernandes, Catarina, Dinh, Cuong V., Walraven, Iris, Heijmink, Stijn W., Smolic, Milena, van Griethuysen, Joost J.M., Simões, Rita, Losnegård, Are, van der Poel, Henk G., Pos, Floris J., van der Heide, Uulke A.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2018
Assuntos:
Original Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807756/
https://ncbi.nlm.nih.gov/pubmed/33458399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phro.2018.06.005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares